Peeking Beneath the Surface of Atopic Dermatitis: Testing Your Skills from Pathogenesis to TreatmentPremiere Date: Wednesday, June 13, 2018
This activity offers CE credit for:%>
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, June 13, 2019
Note: Credit Is No Longer Available
|Zelma C. Chiesa Fuxench, MD, MSCE
Assistant Professor of Dermatology
Department of Dermatology
University of Pennsylvania Perelman School of Medicine
|Aaron Drucker, MD, ScM, FRCPC
Assistant Professor, Department of Medicine, University of Toronto
Scientist, Women's College Research Institute
Division of Dermatology, Department of Medicine, Women's College Hospital
Atopic dermatitis (AD) is a challenging disease for both patients and healthcare providers. It has been hypothesized that early diagnosis and better treatment of AD at the primary care level may reduce the risk of allergy and asthma, thus decreasing patient distress and lowering future medical costs. While there is not yet a cure for AD, new treatments are available to manage the condition and offer new hope for patients and clinicians.
In this CME Outfitters recorded symposium expert faculty provide new insights into AD and will strengthen clinicians' knowledge about the pathophysiology of AD, improve early diagnosis. and share practical insights, evidence and expertise about new agents for the treatment of AD.
At the end of this CE activity, participants should be able to:
- Apply knowledge of the pathogenesis of atopic dermatitis (AD) to make better informed treatment decisions.
- Increase identification of signs and symptoms of AD by 25% to improve differential diagnosis.
- Integrate data from recent clinical trials on novel treatment strategies into clinical practice to optimize patient outcomes.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Explain the pathogenesis of atopic dermatitis (AD) and how it leads to more informed treatment decisions.
- Identify signs and symptoms that can improve differential diagnosis.
- Discuss data from recent clinical trials on novel treatment strategies that can optimize patient outcomes.
Supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Primary care physicians, internists, dermatologists, physician assistants, nurse practitioners, nurses, and pharmacists who treat patients with atopic dermatitis.
CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours
Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.
Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Zelma C. Chiesa Fuxench disclosed that she does research support for Regeneron Pharmaceuticals; sanofi-aventis U.S. LLC; Tioga Pharmaceuticals; Vanda Pharmaceuticals. She is a consultant for the Asthma and Allergy Foundation of America and the National Eczema Association.
Dr. Aaron Drucker disclosed that he received grants from Regeneron Pharmaceuticals and participated in an investigator-initiated research grant with sanofi-aventis U.S. LLC but did not receive a salary or honoraria for the latter. He is a consultant for sanofi-aventis U.S. LLC.
Sharon Tordoff(planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).